Evidence map›Paper›PMID 26820121›Full record

ArticleOncology reports2016

MiRNA-10b sponge: An anti-breast cancer study in vitro.

Ai-Ling Liang, Ting-Ting Zhang, Ning Zhou, Cui Yun Wu, Man-Hua Lin, Yong-Jun Liu

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ai-Ling LiangMedical Molecular Diagnostics Key Laboratory of Guangdong, and Departments of Biochemistry and Molecular Biology and Clinical Biochemistry, Guangdong Medical University, Dongguan, Guangdong 523808, P.R. China.
Ting-Ting ZhangDepartment of Clinical Laboratory, Huangshi City Central Hospital, Huangshi, Hubei 415000, P.R. China.
Ning ZhouMedical Molecular Diagnostics Key Laboratory of Guangdong, and Departments of Biochemistry and Molecular Biology and Clinical Biochemistry, Guangdong Medical University, Dongguan, Guangdong 523808, P.R. China.
Cui Yun WuMedical Molecular Diagnostics Key Laboratory of Guangdong, and Departments of Biochemistry and Molecular Biology and Clinical Biochemistry, Guangdong Medical University, Dongguan, Guangdong 523808, P.R. China.
Man-Hua LinDepartment of Clinical Hematology Testing, Guangdong Medical University, Dongguan, Guangdong 523808, P.R. China.
Yong-Jun LiuMedical Molecular Diagnostics Key Laboratory of Guangdong, and Departments of Biochemistry and Molecular Biology and Clinical Biochemistry, Guangdong Medical University, Dongguan, Guangdong 523808, P.R. China.
Guangdong Medical College · CNHuangshi Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a malignant tumor with the highest incidence among women. Breast cancer metastasis is the major cause of treatment failure and mortality among such patients. MicroRNAs (miRNAs) are a class of small molecular non-coding regulatory RNAs, which act as oncogenes or tumor suppressors in breast cancer. miRNA-10b has been found to exhibit a high expression level in advanced and metastatic breast cancer, and is closely related to breast cancer metastasis. An miRNA sponge is an mRNA with several repeated sequences of complete or incomplete complementarity to the natural miRNA in its 3' non-translating region. It acts as a sponge adsorbing miRNAs and ensures their separation from their targets and inhibits their function. The present study designed a sponge plasmid against miRNA-10b and transiently transfected it into high and low metastatic human breast cancer cell lines MDA-MB-231 and MCF-7, and analyzed the effects of the miRNA-10b sponge on the growth and proliferation, migration and invasion in these cell lines. qRT-PCR results found that the sponge plasmid effectively inhibited the expression of miRNA-10b, and upregulated the expression of the miRNA‑10b target protein HOXD-10. The results from the CCK-8 assay found that the miRNA-10b sponge inhibited the growth of breast cancer cell lines MDA-MB-231 and MCF-7. Results of the plate cloning experiments indicated that the miRNA-10b sponge suppressed the colony formation of the MDA-MB-231 and MCF-7 cells. The results of wound healing and Transwell assays showed that the miRNA-10b sponge inhibited the migration and invasion of the breast cancer cell lines MDA-MB-231 and MCF-7. Our results demonstrated that the miRNA-10b sponge effectively inhibited the growth and proliferation of breast cancer MDA-MB-231 and MCF-7 cells. In addition, it also restrained the migration and invasion of human highly metastatic breast cancer MDA-MB-231 cells.

Indexed as

Breast NeoplasmsCell Line, TumorCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansIn Vitro TechniquesMCF-7 CellsMicroRNAsMolecular Targeted TherapyNeoplasm InvasivenessPlasmidsRNA, MessengerTranscription FactorsMicroRNAsMIRN10 microRNA, humanRNA, MessengerTranscription Factors

Identifiers

PMID26820121
PMCPMC4774667
OpenAlexW2268692045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.